Cigna Corporation (CI) is a Healthcare stock trading at $280.36 (as of 2026-08-24), with a market capitalization of $74.08B and a trailing P/E of 11.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Cigna provides insurance and related health services in the United States and internationally. Its Evernorth segment offers health services such as pharmacy and benefits management, care delivery and management, and intelligence solutions, while its Cigna Healthcare segment delivers medical and related coverage, including products for Medicare and individual plans, for health plans, employers, government organizations, care providers, and insured or self-insured customers.
Cigna provides health insurance and related services, it earns money from its Evernorth health services (including pharmacy, benefits management, care delivery and management, and intelligence solutions) and from its Cigna Healthcare offerings (medical and related benefits for insured and self-insured customers, including Medicare Advantage and Medicare Supplement).
Cigna’s profit engine is the combination of insurance coverage (Cigna Healthcare, including Medicare products) and large, service-led revenue from Evernorth, where pharmacy and benefits management are a core part of how value is delivered to health plans, employers, government organizations, and healthcare providers.
Business quality (Weak): Well-structured two-segment healthcare model (Cigna Healthcare, Evernorth) with a service component that can diversify beyond pure underwriting, but operating performance is likely sensitive to healthcare utilization and the economics of its pharmacy and benefits management services.
Valuation: At 13× earnings, CI trades in line with the Insurance average (13×). Note: one-time items can distort reported P/E.
| Price | $280.36 |
| Market Cap | $74.08B |
| P/E Ratio | 11.9 |
| EV / EBITDA | 5.6 |
| Price / Book | 1.73 |
| Price / Sales | 0.26 |
| DCF Value (model) | $434.08 |
| DCF Upside vs Price | 54.8% |
| Revenue (TTM) | $274.90B |
| Net Margin | 2.2% |
| Revenue Growth (YoY) | 6.7% |
| EPS Growth (YoY) | 9.5% |
| Altman Z-Score | 2.67 (grey) |
| Piotroski F-Score | 8/9 (strong) |
| Stock P/E | 11.9 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Insurance) | 13.1 |
| vs Sector | -45.2% |
| vs Industry | -9.0% |
| Top Institutional Holder | VANGUARD GROUP INC ($7.20B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 10 |
| Sector | Healthcare |
| Industry | Insurance |
| CEO | David Michael Cordani |
| Employees | 71,295 |
| Country | US |
| IPO Date | 1982-03-31 |
Data as of 2026-08-24.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.